This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC for full statistics.
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
C3_RESPIRATORY_INTRATHORACIC3_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
18 |
4. Check minimum number of eventsNone |
18 |
5. Include endpointsNone |
18 |
6. Filter based on genotype QC (FinnGen only) |
18 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 18 | - | 15 |
| Unadjusted period prevalence (%) | 0.01 | - | 0.01 |
| Median age at first event (years) | 80.24 | - | 80.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
5
5
13.07
3.17
1.2
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
0
34
0.00
1.33
0.0
1.5
—
21.0
—
0
26
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
0
32
0.00
1.31
0.0
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
0
25
0.00
0.87
0.0
4.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
0
23
0.00
0.86
0.0
3.9
—
0.0
—
0
6
(3006504) Eosinophils/100 leukocytes in Blood
7
42
2.08
0.80
3.4
4.6
%
2.0
2.7
—
7
37
(3002030) Lymphocytes/100 leukocytes in Blood
7
42
2.08
0.80
3.4
4.7
%
22.1
21.5
—
7
37
(3018010) Neutrophils/100 leukocytes in Blood
7
42
2.08
0.80
3.4
4.5
%
60.6
62.5
—
7
36
(3019069) Monocytes/100 leukocytes in Blood
7
42
2.08
0.80
3.4
4.7
%
10.4
9.2
—
7
37
(3022096) Basophils/100 leukocytes in Blood
7
42
2.08
0.80
3.4
4.6
%
0.7
0.5
—
7
37
(40768804) Tissue Pathology biopsy report
6
36
1.99
0.65
2.7
2.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
7
45
1.90
0.59
3.4
4.4
e9/l
1.4
1.7
—
7
40
(3001604) Monocytes [#/volume] in Blood
7
45
1.90
0.59
3.4
4.4
e9/l
0.7
0.7
—
7
38
(3006315) Basophils [#/volume] in Blood
7
46
1.85
0.58
3.4
4.3
e9/l
0.0
0.0
—
7
39
(3013115) Eosinophils [#/volume] in Blood
7
47
1.79
0.57
3.7
4.5
e9/l
0.1
0.2
—
7
40
(42870588) Differential panel, method unspecified - Blood
5
31
1.84
0.48
2.8
3.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
0
16
0.00
0.43
0.0
4.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
16
0.00
0.43
0.0
12.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.42
0.0
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6
45
1.50
0.39
3.7
5.5
mmol/l
1.2
1.2
—
6
39
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6
79
0.64
0.34
3.8
6.9
mmol/mol
42.2
44.4
—
6
72
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6
78
0.66
0.33
4.3
4.2
mu/l
2.5
2.5
—
6
63
(40761511) CBC panel - Blood by Automated count
7
87
0.68
0.33
20.4
18.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
7
58
1.34
0.22
10.0
7.5
e9/l
4.3
5.2
—
7
49
(3007164) IgA [Mass/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
1.0
—
3.8
—
0
6
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
0
11
0.00
0.22
0.0
3.6
—
22.7
—
0
11
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
11
0.00
0.22
0.0
1.6
—
—
—
0
0
(3012544) pH of Venous blood
0
10
0.00
0.22
0.0
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
10
0.00
0.22
0.0
4.5
—
1.0
—
0
10
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
10
0.00
0.22
0.0
4.5
—
0.5
—
0
10
(3000991) Gas panel - Venous blood
0
10
0.00
0.22
0.0
4.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
10
0.00
0.22
0.0
4.5
—
95.0
—
0
10
(40761535) Cells panel - Urine sediment
0
12
0.00
0.22
0.0
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
5
67
0.65
0.22
5.0
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5
64
0.70
0.21
4.4
5.2
ug/l
3.6
2.8
—
5
54
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
0
14
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
8
95
0.72
0.21
29.3
27.9
e12/l
4.3
4.2
—
8
89
(3010813) Leukocytes [#/volume] in Blood
8
95
0.72
0.21
29.3
27.9
e9/l
6.8
7.2
—
8
89
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7
82
0.76
0.20
24.9
18.7
ml/min/173m2
64.9
66.4
—
7
62
(3020564) Creatinine [Moles/volume] in Serum or Plasma
8
92
0.77
0.20
27.6
22.7
umol/l
90.8
92.1
—
8
92
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5
44
1.19
0.11
2.6
4.3
mmol/l
1.3
1.2
—
5
37
(3023368) Bacteria identified in Blood by Culture
5
45
1.15
0.11
2.0
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8
88
0.84
0.09
17.0
20.4
mg/l
38.1
38.6
—
8
74
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
8
75
1.12
0.09
13.4
6.5
u/l
103.0
76.2
—
8
70
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
2.8
3.3
pmol/l
13.5
14.9
—
6
47
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
20.6
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
1.8
—
0
5
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
1.3
—
0
8
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5
50
1.00
0.00
1.8
2.3
u/l
103.2
58.0
—
5
41
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).